ATE473233T1 - Neue morphinderivate - Google Patents

Neue morphinderivate

Info

Publication number
ATE473233T1
ATE473233T1 AT07858552T AT07858552T ATE473233T1 AT E473233 T1 ATE473233 T1 AT E473233T1 AT 07858552 T AT07858552 T AT 07858552T AT 07858552 T AT07858552 T AT 07858552T AT E473233 T1 ATE473233 T1 AT E473233T1
Authority
AT
Austria
Prior art keywords
morphine derivatives
new morphine
new
derivatives
pharmaceutical compositions
Prior art date
Application number
AT07858552T
Other languages
English (en)
Inventor
Karine Larbouret
Roger Lahana
Cedric Castex
Original Assignee
Neorphys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neorphys filed Critical Neorphys
Application granted granted Critical
Publication of ATE473233T1 publication Critical patent/ATE473233T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT07858552T 2006-10-12 2007-10-11 Neue morphinderivate ATE473233T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0654247A FR2907121B1 (fr) 2006-10-12 2006-10-12 Nouveaux derives morphiniques
PCT/FR2007/052122 WO2008043962A1 (fr) 2006-10-12 2007-10-11 Nouveaux derives morphiniques

Publications (1)

Publication Number Publication Date
ATE473233T1 true ATE473233T1 (de) 2010-07-15

Family

ID=38038630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07858552T ATE473233T1 (de) 2006-10-12 2007-10-11 Neue morphinderivate

Country Status (20)

Country Link
US (1) US8158764B2 (de)
EP (1) EP2081944B1 (de)
JP (1) JP5180219B2 (de)
KR (1) KR20090079232A (de)
CN (1) CN101522700B (de)
AT (1) ATE473233T1 (de)
AU (1) AU2007306226C1 (de)
CA (1) CA2664569A1 (de)
CY (1) CY1110787T1 (de)
DE (1) DE602007007653D1 (de)
DK (1) DK2081944T3 (de)
ES (1) ES2347020T3 (de)
FR (1) FR2907121B1 (de)
IL (1) IL197769A (de)
PL (1) PL2081944T3 (de)
PT (1) PT2081944E (de)
RU (1) RU2426736C2 (de)
SI (1) SI2081944T1 (de)
WO (1) WO2008043962A1 (de)
ZA (1) ZA200903193B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2939437B1 (fr) * 2008-12-10 2010-12-17 Sanofi Aventis Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique
FR2939796B1 (fr) * 2008-12-11 2010-12-17 Sanofi Aventis Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique
US20180071269A1 (en) 2015-08-12 2018-03-15 Tianxin Wang Therapeutical methods, formulations and nutraceutical formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2318687A (en) 1943-05-11 Means fob determining the sex of
US4939264A (en) * 1986-07-14 1990-07-03 Abbott Laboratories Immunoassay for opiate alkaloids and their metabolites; tracers, immunogens and antibodies
GB9116909D0 (en) 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
EP0816375A1 (de) * 1995-11-29 1998-01-07 Rolabo Sl Glycokonjugate von opiaten
DE19602968A1 (de) 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
ES2201482T3 (es) 1997-04-14 2004-03-16 Ufc Limited Derivados de la morfina.
GB9711118D0 (en) * 1997-05-29 1997-07-23 Rolabo Sl Compound
WO1999064430A2 (en) 1998-06-06 1999-12-16 Cenes Limited Morphine-6-glucuronide synthesis
FR2821272B1 (fr) * 2001-02-23 2004-12-17 Synt Em Composes constitues d'une molecule analgesique liee a un vecteur capable de vectoriser ladite molecule a travers la barriere hematoencephalique et compositions pharmaceutiques les contenant
NZ528935A (en) 2001-03-16 2004-10-29 Dmi Biosciences Inc Method of delaying ejaculation
BRPI0408059A (pt) * 2003-02-28 2006-02-14 Delex Therapeutics Inc sistema de administração de opióides
FR2864082B1 (fr) * 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur
US20090233841A1 (en) * 2005-01-05 2009-09-17 Regents Of The University Of Minnesota Analgesic conjugates
US7576207B2 (en) * 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use

Also Published As

Publication number Publication date
KR20090079232A (ko) 2009-07-21
RU2009117467A (ru) 2010-11-20
JP5180219B2 (ja) 2013-04-10
DK2081944T3 (da) 2010-09-20
CN101522700B (zh) 2012-08-22
RU2426736C2 (ru) 2011-08-20
CN101522700A (zh) 2009-09-02
IL197769A0 (en) 2009-12-24
IL197769A (en) 2013-07-31
AU2007306226B2 (en) 2012-01-19
ES2347020T3 (es) 2010-10-22
WO2008043962A1 (fr) 2008-04-17
EP2081944B1 (de) 2010-07-07
FR2907121A1 (fr) 2008-04-18
ZA200903193B (en) 2010-03-31
DE602007007653D1 (de) 2010-08-19
US8158764B2 (en) 2012-04-17
PL2081944T3 (pl) 2010-12-31
AU2007306226A1 (en) 2008-04-17
HK1131156A1 (en) 2010-01-15
PT2081944E (pt) 2010-08-31
EP2081944A1 (de) 2009-07-29
JP2010505923A (ja) 2010-02-25
FR2907121B1 (fr) 2012-05-04
US20100075912A1 (en) 2010-03-25
CA2664569A1 (fr) 2008-04-17
CY1110787T1 (el) 2015-06-10
SI2081944T1 (sl) 2010-11-30
AU2007306226C1 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
EA200802008A1 (ru) Фармацевтические композиции
ATE447568T1 (de) Neue pyrinderivate
EP4125244C0 (de) Hash-basiertes multihoming
ATE481383T1 (de) 3-aza-bicycloä3.1.0ühexanderivate
BRPI0716094A2 (pt) composiÇço de resina.
ATE469145T1 (de) 4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl-
BRPI0922911A2 (pt) "unidade de cilindro de gás".
HUE041959T2 (hu) Kannabinoid-tartalmú extraktumok, mint neuroprotektív ágensek
LT3492069T (lt) Farmacinės kompozicijos, apimančios geležies oksihidroksidą
EP2083927A4 (de) Versteckter sprinkler
BRPI0715712A2 (pt) Composição farmacêutica
PT2878307T (pt) Composição imunogénica.
BRPI0719393A2 (pt) Composição farmacêutica
BRPI0716046A2 (pt) composiÇÕes de nanopartÍcula.
BRPI0720234A2 (pt) Composição farmacêutica
BRPI0716445A2 (pt) composiÇço farmacÊutica
DE602007001681D1 (de) 1,3-dioxan-carboxylsäuren
FR2900034B1 (fr) Poudrier.
FR2923713B1 (fr) Composition reductrice epaissie.
DE602007007653D1 (de) Neue morphinderivate
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
NO20091386L (no) Fenyloksyanilinderivater
BRPI0811431A2 (pt) Composição farmacêutica aquosa.
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе
FR2898787B1 (fr) Equerre.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2081944

Country of ref document: EP